(Q52001000)

19 April 2018

title

Differential CSF biomarker levels in APOE-epsilon4-positive and -negative patients with memory impairment. (English)

1 reference

19 April 2018

1 reference

7

1 reference

19 April 2018

Ove Almkvist

object named as

Ove Almkvist

4

0 references

Kaj Blennow

2

object named as

Kaj Blennow

1 reference

19 April 2018

Christin Andersson

1

1 reference

19 April 2018

Sven-Erik Johansson

3

1 reference

19 April 2018

Peter Engfeldt

5

1 reference

19 April 2018

Maria Lindau

6

1 reference

19 April 2018

publication date

22 November 2006

1 reference

19 April 2018

Dementia and Geriatric Cognitive Disorders

published in

1 reference

19 April 2018

volume

23

1 reference

19 April 2018

issue

2

1 reference

19 April 2018

page(s)

87-95

1 reference

19 April 2018

Mild cognitive impairment: clinical characterization and outcome

cites work

1 reference

Identifying patients at high and low risk of cognitive decline using Rey Auditory Verbal Learning Test among middle-aged memory clinic outpatients.

21 January 2018

1 reference

Recognition memory and verbal fluency differentiate probable Alzheimer disease from subcortical ischemic vascular dementia

21 January 2018

1 reference

Neuropsychological deficit in early subcortical vascular dementia: comparison to Alzheimer's disease

21 January 2018

1 reference

A preclinical phase in vascular dementia: cognitive impairment three years before diagnosis.

21 January 2018

1 reference

Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease

21 January 2018

1 reference

High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype.

21 January 2018

1 reference

Relationship between apoE genotype and CSF beta-amyloid (1-42) and tau in patients with probable and definite Alzheimer's disease.

21 January 2018

1 reference

Dependence of cerebrospinal fluid Tau protein levels on apolipoprotein E4 allele frequency in patients with Alzheimer's disease.

21 January 2018

1 reference

Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele

21 January 2018

1 reference

21 January 2018

1 reference

Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization.

21 January 2018

1 reference

Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease.

21 January 2018

1 reference

Neuropathological stageing of Alzheimer-related changes

21 January 2018

1 reference

Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000097354

1 reference

19 April 2018

1 reference

19 April 2018